Sort by
Refine Your Search
-
for combat trauma, directed energy exposure, extreme environmental exposure, and/or toxicant exposure. You will participate in and learn to perform data collection and analysis pertaining to testing toxicants
-
. Start date is flexible and will depend on a variety of factors. Appointment Length: The appointment will initially be for one year but may be renewed upon recommendation of ARS and is contingent
-
just medicines. Research Project: This research project addresses critical knowledge gaps in emerging therapeutic modalities, specifically immune cell engagers and radioligand therapies, where limited
-
the possibility to be renewed for additional research periods. Appointments may be extended depending on funding availability, project assignment, program rules, and availability of the participant. What
-
, 2026. Start date is flexible and will depend on a variety of factors. Appointment Length: The appointment will initially be for one year but may be renewed upon recommendation of APHIS and is contingent
-
for one year but may be renewed upon recommendation of ARS and is contingent on the availability of funds. Level of Participation: The appointment is full time. Participant Stipend: The participant will
-
Appointment Start Date: March 2026 or earlier. Start date is flexible and will depend on a variety of factors. Appointment Length: The appointment will initially be for two years, but may be renewed upon
-
and will depend on a variety of factors. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds
-
renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full time. Participant Stipend: The participant will receive a monthly stipend
-
. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full